JP Stock MarketDetailed Quotes

4547 Kissei Pharmaceutical

Watchlist
  • 3445
  • -100-2.82%
20min DelayNot Open Aug 26 15:00 JST
169.88BMarket Cap13.97P/E (Static)

Kissei Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Kissei Pharmaceutical Q1 2025 Earnings Date

Currency：JPYJul 30, 2024

Estimate
(YoY)		 Actual
(YoY)		 Vs Estimate
(% Chg)
Revenue
19.80B
21.16B
+1.36B
Beat Est.
+2.52%
+9.58%
+6.89%
EPS
56.60
92.89
+36.29
Beat Est.
-20.23%
+30.92%
+64.12%
Analyst Rating
Hold

Aug 22, 2024

Kissei Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2027/Q1-- / 22.300B--
--2026/Q1-- / 21.300B--
Jul 30, 20242025/Q121.164B / 19.800B--
Jan 30, 20242024/Q320.881B / ----
Jul 31, 20232024/Q119.313B / 17.750B--
DatePeriodRevenue/EstimateEarnings Call
--2027/Q1-- / 22.300B--
--2026/Q1-- / 21.300B--
Jul 30, 20242025/Q121.164B / 19.800B--
Jan 30, 20242024/Q320.881B / ----
Jul 31, 20232024/Q119.313B / 17.750B--

Unlock Free Earnings Estimates

Kissei Pharmaceutical Earnings Reports

  • Kissei Pharmaceutical: Supplementary financial data for the first quarter of the March 2025 period.

    Jul 30 02:00 ET

  • Kissei Pharmaceutical: Short message of Q1 financial results for March 2025 (consolidated, Japanese standard).

    Jul 30 02:00 ET

  • Kissei Pharmaceutical: Extraordinary Report

    Jun 28 00:00 ET

  • Kissei Pharmaceutical: Securities Report - 79th Fiscal Year (April 1, 2023 - March 31, 2024)

    Jun 25 00:00 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Aug 22, 2024

    Hold

    • Strong Buy

      0.00%

    • Buy

      33.33%

    • Hold

      66.67%

    • Underperform

      0.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    % Chg